Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow Post author:Sam Post published:November 29, 2017 Post category:BioPharma Sanofi’s setback could open the door for rival drugmaker Takeda. Source: BioSpace You Might Also Like Pfizer Terminates PDC Agreement with CytomX Therapeutics March 7, 2018 Actelion's R&D Discovery Biz Gets a Name, March 14, 2017 Former Google Exec Steps Down as GRAIL CEO August 2, 2017
